Puglisi, S.; Calabrese, A.; Basile, V.; Ceccato, F.; Scaroni, C.; Simeoli, C.; Torlontano, M.; Cannavò, S.; Arnaldi, G.; Stigliano, A.;
et al. Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment. J. Clin. Med. 2019, 8, 1850.
https://doi.org/10.3390/jcm8111850
AMA Style
Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A,
et al. Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment. Journal of Clinical Medicine. 2019; 8(11):1850.
https://doi.org/10.3390/jcm8111850
Chicago/Turabian Style
Puglisi, Soraya, Anna Calabrese, Vittoria Basile, Filippo Ceccato, Carla Scaroni, Chiara Simeoli, Massimo Torlontano, Salvatore Cannavò, Giorgio Arnaldi, Antonio Stigliano,
and et al. 2019. "Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment" Journal of Clinical Medicine 8, no. 11: 1850.
https://doi.org/10.3390/jcm8111850
APA Style
Puglisi, S., Calabrese, A., Basile, V., Ceccato, F., Scaroni, C., Simeoli, C., Torlontano, M., Cannavò, S., Arnaldi, G., Stigliano, A., Malandrino, P., Saba, L., Altieri, B., Della Casa, S., Perotti, P., Berchialla, P., De Filpo, G., Canu, L., Loli, P.,
... Terzolo, M.
(2019). Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment. Journal of Clinical Medicine, 8(11), 1850.
https://doi.org/10.3390/jcm8111850
